Adjuvant Pembrolizumab in Stage II Melanoma: Outcomes by Primary Tumor Location in the Randomized, Double-Blind, Phase III KEYNOTE-716 Trial.
Annals of Surgical Oncology（2025）
Key words
Adjuvant,Surgery,Immune checkpoint inhibitors,Melanoma,Skin neoplasms,Pembrolizumab,Adjuvant therapy
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined